2508 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2024
JOURNALArchives of gynecology and obstetrics
PREMIER AUTEURPavone M
TITREEfficacy and safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in ovarian cancer: a systematic review of current evidence.
ANNÉE2024
JOURNALEBioMedicine
PREMIER AUTEURLecuelle J
TITREMachine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts.
ANNÉE2024
JOURNALArchives of cardiovascular diseases
PREMIER AUTEURDidier R
TITREDeaths and major cardiovascular events in patients with lymphoma: Analysis from a French nationwide hospitalization database.
ANNÉE2024
JOURNALEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
PREMIER AUTEURRaimond E
TITREImpact of age on tumor size in vulvar cancer: A multicenter study by the Francogyn group.
ANNÉE2024
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEURRiou O
TITREIs neoadjuvant folfox an effective treatment only in a very selected favorable subgroup of locally advanced rectal cancer?
ANNÉE2024
JOURNALPharmaceutics
PREMIER AUTEURKalenichenko D
TITRECytotoxic Effects of Doxorubicin on Cancer Cells and Macrophages Depend Differently on the Microcarrier Structure.
ANNÉE2024
JOURNALJournal de mycologie medicale
PREMIER AUTEURSautour M
TITRERisk of fungal exposure in the homes of patients with hematologic malignancies.
ANNÉE2024
JOURNALJournal of neuro-oncology
PREMIER AUTEURZinsz A
TITREAmino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.
ANNÉE2024
JOURNALESMO open
PREMIER AUTEURHoang TCT
TITRERisk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts.
ANNÉE2024
JOURNALClinical genitourinary cancer
PREMIER AUTEURMoinard-Butot F
TITREEffect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques